THE COST-EFFECTIVENESS OF DENOSUMAB FOR THE PREVENTION OF OSTEOPOROTIC FRACTURES IN THE SETTING OF THE UNITED STATES

被引：3
|
作者：
Jiang, Y. [1 ]
Hay, J. [2 ]
机构：
[1] USC Sch Pharm, Los Angeles, CA USA
[2] Univ So Calif, Los Angeles, CA USA
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 04期
关键词：
D O I：
10.1016/j.jval.2012.03.216
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A38 / A38
页数：1
相关论文
共 50 条
  • [41] Cost-effectiveness analysis in the United States - Reply
    Pearson, SD
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (23): : 2722 - 2723
  • [42] Update on the cost-effectiveness of contraceptives in the United States
    Trussell, James
    Sinai, Irit
    [J]. CONTRACEPTION, 2010, 82 (04) : 391 - 392
  • [43] Cost-Effectiveness of Sequential Abaloparatide/Alendronate in Men at High Risk of Fractures in the United States
    Hiligsmann, Mickael
    Silverman, Stuart S.
    Singer, Andrea J.
    Pearman, Leny
    Mathew, Jake
    Wang, Yamei
    Caminis, John
    Reginster, Jean-Yves
    [J]. PHARMACOECONOMICS, 2023, 41 (07) : 819 - 830
  • [44] Cost-Effectiveness of Hormone Therapy in the United States
    Lekander, Ingrid
    Borgstrom, Fredrik
    Strom, Oskar
    Zethraeus, Niklas
    Kanis, John A.
    [J]. JOURNAL OF WOMENS HEALTH, 2009, 18 (10) : 1669 - 1677
  • [45] Prevention of osteoporotic fractures in Dutch men and women: A cost effectiveness evaluation
    De Laet, CE
    Pols, HAP
    [J]. BONE, 2001, 28 (05) : S93 - S93
  • [46] The cost-effectiveness of raloxifene compared with no drug therapy for the prevention of osteoporotic fractures when HRT is inappropriate: The case of Australia
    Davey, P
    Lees, M
    Graham-Clarke, P
    [J]. VALUE IN HEALTH, 2002, 5 (06) : 455 - 456
  • [47] COST-EFFECTIVENESS OF ROSUVASTATIN 20 MG IN SECONDARY-PREVENTION PATIENTS IN THE UNITED STATES
    Ohsfeldt, R.
    Gandhi, S. K.
    Jensen, M. M.
    Smolen, L.
    Fox, K. M.
    Hsia, J.
    Gold, A.
    [J]. VALUE IN HEALTH, 2010, 13 (03) : A162 - A162
  • [48] Cost-effectiveness of zoledronic acid compared with sequential denosumab/alendronate for older osteoporotic women in Japan
    Takahiro Mori
    Carolyn J. Crandall
    Tomoko Fujii
    David A. Ganz
    [J]. Archives of Osteoporosis, 2021, 16
  • [49] Cost and cost-effectiveness of increasing access to sterile syringes and needles as an HIV prevention intervention in the United States
    Holtgrave, DR
    Pinkerton, SD
    Jones, TS
    Lurie, P
    Vlahov, D
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1998, 18 : S133 - S138
  • [50] Cost-effectiveness of zoledronic acid compared with sequential denosumab/alendronate for older osteoporotic women in Japan
    Mori, Takahiro
    Crandall, Carolyn J.
    Fujii, Tomoko
    Ganz, David A.
    [J]. ARCHIVES OF OSTEOPOROSIS, 2021, 16 (01)
12345